Viewing Study NCT05043402


Ignite Creation Date: 2025-12-25 @ 3:44 AM
Ignite Modification Date: 2025-12-26 @ 2:30 AM
Study NCT ID: NCT05043402
Status: UNKNOWN
Last Update Posted: 2022-08-15
First Post: 2021-09-07
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study of Navicixizumab in Patients With Platinum Resistant Ovarian Cancer
Sponsor: OncXerna Theraputics, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module